Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03409458 |
| Title | A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab (PAVE-1) |
| Acronym | PAVE-1 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Phosplatin Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Arizona | Phoenix | Arizona | 85054 | United States | Details | |
| Colorado | Aurora | Colorado | 80045 | United States | Details | |
| Florida | Jacksonville | Florida | 32224 | United States | Details | |
| Minnesota | Rochester | Minnesota | 55905 | United States | Details | |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Lausanne | Lausanne | 1011 | Switzerland | Details |